Literature DB >> 10359011

p53 is a transcriptional activator of the muscle-specific phosphoglycerate mutase gene and contributes in vivo to the control of its cardiac expression.

P Ruiz-Lozano1, M L Hixon, M W Wagner, A I Flores, S Ikawa, A S Baldwin, K R Chien, A Gualberto.   

Abstract

The role that the p53 tumor suppressor gene product plays in cellular differentiation remains controversial. However, recent evidence indicates that p53 is required for proper embryogenesis. We have studied the effect of p53 on the expression mediated by the promoter of the rat muscle-specific phosphoglycerate mutase gene (M-PGAM), a marker for cardiac and skeletal muscle differentiation. Experiments involving transient transfection, mobility shift assay, and site-directed mutagenesis demonstrated that p53 specifically binds and transactivates the M-PGAM promoter. The p53-related proteins p51A and p73L also transactivated M-PGAM. Moreover, stable expression of a p53 dominant mutant in C2C12 cells blocked the induction of M-PGAM expression during the myoblast to myotube transition and the ability of p53, p51A, and p73L to transactivate the M-PGAM promoter. In addition, impaired expression of M-PGAM was observed in a subset of p53-null animals in heart and muscle tissues of anterior-ventral location. These results demonstrate that p53 is a transcriptional activator of M-PGAM that contributes in vivo to the control of its cardiac expression. These data support previous findings indicating a role for p53 in cellular differentiation.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10359011

Source DB:  PubMed          Journal:  Cell Growth Differ        ISSN: 1044-9523


  35 in total

Review 1.  p53 regulation of metabolic pathways.

Authors:  Eyal Gottlieb; Karen H Vousden
Journal:  Cold Spring Harb Perspect Biol       Date:  2009-12-02       Impact factor: 10.005

Review 2.  The role of p53 in cell metabolism.

Authors:  Xing-ding Zhang; Zheng-hong Qin; Jin Wang
Journal:  Acta Pharmacol Sin       Date:  2010-08-23       Impact factor: 6.150

3.  Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species.

Authors:  Sawako Suzuki; Tomoaki Tanaka; Masha V Poyurovsky; Hidekazu Nagano; Takafumi Mayama; Shuichi Ohkubo; Maria Lokshin; Hiroyuki Hosokawa; Toshinori Nakayama; Yutaka Suzuki; Sumio Sugano; Eiichi Sato; Toshitaka Nagao; Koutaro Yokote; Ichiro Tatsuno; Carol Prives
Journal:  Proc Natl Acad Sci U S A       Date:  2010-03-29       Impact factor: 11.205

Review 4.  Dysregulated glycolysis as an oncogenic event.

Authors:  Takumi Mikawa; Matilde E LLeonart; Akifumi Takaori-Kondo; Nobuya Inagaki; Masayuki Yokode; Hiroshi Kondoh
Journal:  Cell Mol Life Sci       Date:  2015-01-22       Impact factor: 9.261

Review 5.  p53, aerobic metabolism, and cancer.

Authors:  Cory U Lago; Ho Joong Sung; Wenzhe Ma; Ping-yuan Wang; Paul M Hwang
Journal:  Antioxid Redox Signal       Date:  2011-04-14       Impact factor: 8.401

Review 6.  Glucose metabolism in gastric cancer: The cutting-edge.

Authors:  Lian-Wen Yuan; Hiroharu Yamashita; Yasuyuki Seto
Journal:  World J Gastroenterol       Date:  2016-02-14       Impact factor: 5.742

Review 7.  Stress eating and tuning out: cancer cells re-wire metabolism to counter stress.

Authors:  Zachary E Stine; Chi V Dang
Journal:  Crit Rev Biochem Mol Biol       Date:  2013-10-07       Impact factor: 8.250

Review 8.  ROS and p53: a versatile partnership.

Authors:  Bin Liu; Yumin Chen; Daret K St Clair
Journal:  Free Radic Biol Med       Date:  2008-01-26       Impact factor: 7.376

Review 9.  The role of the p53 tumor suppressor in metabolism and diabetes.

Authors:  Che-Pei Kung; Maureen E Murphy
Journal:  J Endocrinol       Date:  2016-09-09       Impact factor: 4.286

Review 10.  p53 and metabolism.

Authors:  Karen H Vousden; Kevin M Ryan
Journal:  Nat Rev Cancer       Date:  2009-09-17       Impact factor: 60.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.